EUVIMEDEUVIMED entdecken
Crossref

Monoclonal Antibody Therapy in Rheumatoid Arthritis: A Paradigm Shift Toward Precision Immunotherapy

Kannaiyan Suria Prabha, Joshua Albert, Daniel Catherine Grace, Selva Kumar Gokul, Sankar Kalai Kumar, Ganesan Shyam Sundar, Ravichandran Udaya Kumar

Journal of Young Pharmacists · 26.06.2026 · 18 (2) · 260-266

DOI: 10.5530/jyp.20260217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Young Pharmacists, online erschienen am 26.06.2026. Verfasst von Kannaiyan Suria Prabha und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Prabha, K. S., Albert, J., Grace, D. C., Gokul, S. K., Kumar, S. K., Sundar, G. S., & Kumar, R. U. (2026). Monoclonal Antibody Therapy in Rheumatoid Arthritis: A Paradigm Shift Toward Precision Immunotherapy. Journal of Young Pharmacists, 18(2), 260-266. https://doi.org/10.5530/jyp.20260217

Vancouver

Prabha KS, Albert J, Grace DC, Gokul SK, Kumar SK, Sundar GS, et al. Monoclonal Antibody Therapy in Rheumatoid Arthritis: A Paradigm Shift Toward Precision Immunotherapy. Journal of Young Pharmacists. 2026;18(2):260-266. doi:10.5530/jyp.20260217

BibTeX
@article{Prabha2026,
  author = {Prabha, Kannaiyan Suria and Albert, Joshua and Grace, Daniel Catherine and Gokul, Selva Kumar and Kumar, Sankar Kalai and Sundar, Ganesan Shyam and Kumar, Ravichandran Udaya},
  title = {Monoclonal Antibody Therapy in Rheumatoid Arthritis: A Paradigm Shift Toward Precision Immunotherapy},
  journal = {Journal of Young Pharmacists},
  year = {2026},
  volume = {18},
  number = {2},
  pages = {260--266},
  doi = {10.5530/jyp.20260217}
}
Kostenlos starten →